AIHTA - Publications - Search - [Rituximab (MabThera®) as treatment for non-Hodgkin's lymphoma]

Wild, C. (2004): [Rituximab (MabThera®) as treatment for non-Hodgkin's lymphoma]. HTA-Newsletter 32: p. 3.

[thumbnail of HTA-Newsletter32.pdf]
Preview
 PDF - Sie müssen einen PDF-Viewer auf Ihrem PC installiert haben wie z. B. GSview, Xpdf oder Adobe Acrobat Reader
121kB

Official URL: http://hw.oeaw.ac.at/ita/hta-newsletter?frames=yes


Item Type:HTA Newsletter Item
Keywords:Non-Hodgkin's lymphoma (NHL), rituximab (MabThera®), monoclonal antibody, drug therapy, combination therapy
Subjects:WH Hemic and lymphatic systems
QW Microbiology. Immunology
Related URLs:
References:1. NHSC/GB 2004: Rituximab for 1st line lowgrade non-Hodgkin's lymphoma: URL: http://pcpoh.bham.ac.uk/publichealth/horizon/PDF_files/2004reports/Rituximab.pdf.

2. NCCHTA/GB 2004: Rituximab for aggressive non-Hodgkin's lymphoma. URL: http://www.ncchta.org/execsumm/summ837.htm.

3. BCBS/USA 2002: Rituximab for treatment of intermediate and aggressive B-cell non-Hodgkin's lymphomas. URL: http://www.bcbs.com/tec/vol17/17_03.html.

4. NCCHTA/GB 2002: Rituximab as thirdline treatment for refractory or recurrent Stage III or IV follicular non-Hodgkin's lymphoma:a systematic review and economic
evaluation. URL: http://www.ncchta.org/execsumm/summ603.htm.
Language:German
Number:32
Deposited on:22 Aug 2007 14:19
Last Modified:15 Jul 2020 17:23

Repository Staff Only: item control page